Colleen M. Craven
Vice President, Corporate Compliance & Business Practices, Endo Pharmaceuticals
(Co chair)
Margaret K. Feltz
Associate Director, Corporate Compliance, Purdue Pharma LP
(Co chair)
Lori Queisser
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation
(Co chair)
Scott Bass, Esq.
Partner, Sidley Austin LLP
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP
Eve Costopoulos
Vice President, Corporate Compliance, Schering-Plough Corporation
Kris Curry
Senior Director, Health Care Compliance Operations, Johnson & Johnson Pharmaceuticals Groups
Wendy C. Goldstein, Esq.
Partner, Epstein Becker & Green
Jeffrey L. Handwerker, Esq.
Partner, Arnold & Porter
Elizabeth V. Jobes, Esq.
Vice President and Chief Compliance Officer, Adolor
|
|
Gregory H. Levine, Esq.
Partner, Ropes & Gray
Matthew M. Malloy, Esq.
Associate General Counsel, The Procter & Gamble Company
Kathleen Meriwether, Esq.
Principal, Fraud Investigation & Dispute Services, Ernst & Young
Brian Riewerts
Partner, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP
Michael Shaw
Global Head, Ethics & Compliance, Novartis Oncology
Doreen F. Shulman
Vice President, Chief Compliance and Ethics Officer, Bristol-Myers Squibb
Paul J. Silver
Managing Director, Practice Leader, Life Sciences Advisory Services, Huron Consulting Group
Peter S. Spivack, Esq.
Partner, Hogan & Hartson
Jack T. Tanselle
Director, Navigant Consulting, Inc.
Caroline West, Esq.
Senior Vice President, Chief Compliance and Risk Officer, Shire Pharmaceuticals, Inc.
|
